# Timeline

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/timeline

- Industry: Biotechnology
- Headquarters: Lausanne, Switzerland
- Website: www.timelinenutrition.com/
- Total disclosed funding: $66M
- Latest round: Series D (Jan 17, 2024)
- Investors on record: 2

## About

Established in 2007 by Patrick Aebischer and Pierre Landolt, and based in Lausanne, Switzerland, Amazentis SA trading under the name Timeline operates as a life sciences and biotechnology company that develops therapeutic products to reverse the aging of mitochondria that enables optimized muscular function. In January 2024, Timeline raised CHF 56 million in Series D funding led by L'Oréal BOLD Ventures, with participation from Nestle Health Science SA and other investors.

Mitopure offers Urolithin A supplements in vegetarian capsules, designed to support healthy aging by enhancing cellular energy and function. Urolithin A is a compound that promotes mitophagy, the recycling process of damaged mitochondria, which is helpful for promoting cellular energy and health.

The company intends to use the January 2024 funding to broaden its product lines and market across the food, beauty, and health industries.

## Funding rounds

- Series D, Jan 17, 2024, $66M — Nestle Health Science SA, Bold

## Investors

- Nestle Health Science SA — Series D
- Bold — Series D